iNOS-derived nitric oxide modulates infection-stimulated bone loss

Journal of Dental Research

Volumn 87, Issue 12, 2008, Pages 1155-1159

  Fukada, S Y ^a   Silva, T A ^b   Saconato, I F ^a   Garlet, G P ^a   Avila Campos, M J ^a   Silva, J S ^a   Cunha, F Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Nitric oxide; OPG; Osteoclastogencsis; RANK; RANKL; SDF 1 CXCL12

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOLOGICAL MARKER; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; NITRIC OXIDE; NOS2 PROTEIN, MOUSE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STROMAL CELL DERIVED FACTOR 1; TARTRATE-RESISTANT ACID PHOSPHATASE; UNCLASSIFIED DRUG;

ACTINOMYCOSIS; ANIMAL; ARTICLE; BACTERIAL INFECTION; BACTEROIDACEAE INFECTION; C57BL MOUSE; CELL COUNT; CELL MOTION; ENDODONTICS; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE STRAIN; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; TOOTH PERIAPICAL DISEASE;

ACID PHOSPHATASE; ACTINOMYCOSIS; ALVEOLAR BONE LOSS; ANIMALS; BACTERIAL INFECTIONS; BACTEROIDACEAE INFECTIONS; BIOLOGICAL MARKERS; CELL COUNT; CELL MOVEMENT; CHEMOKINE CXCL12; DENTAL PULP EXPOSURE; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOCLASTS; OSTEOLYSIS; OSTEOPROTEGERIN; PERIAPICAL PERIODONTITIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 58149391128     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910808701207     Document Type: Article

References (36)

1. Benjamim CF, Silva JS, Fortes ZB, Oliveira MA, Ferreira SH, Cunha FQ (2002), Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun 70:3602-3610.
2. Boyle WJ, Simonet WS, Lacey DL (2003). Osteoclast differentiation and activation. Nature 423:337-342.
3. Brandi ML, Hukkanen M, Umcda T, Moradi-Bidhendi N, Blanchi S, Gross SS, et al. (1995). Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 92:2954-2958.
4. Chae P, Im M, Gibson F, Jiang Y, Graves DT (2002). Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment. Infect Immun 70:3164-3169.
5. Chen CP, Hertzberg M, Jiang Y, Graves DT ( 1999). Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection. Am J Pathol 155:2145-2152.
6. Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M, et al. (2003). Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (ORG) protein expression in periodontitis. J Periodontal Res 38:380-387.
7. Dal Secco D, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha FQ (2003). Neutrophil migration in inflammation; nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 9:153-164.
8. Diwan AD, Wang MX, Jang D, Zhu W, Murrell GA (2000). Nitric oxide modulates fracture healing. J Bone Miner Res 15:342-351.
9. Fan X, Roy E, Zhu L, Murphy TC, Ackert-Bicknell C, Hart CM, et al. (2004). Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology 145:751-759.
10. Fierro IM, Nascimento-DaSilva V, Arruda MA, Freilas MS, Plotkowski MC, Cunha FQ, et al (1999). Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J Leukoc Biol 65:508-514.
11. Gyurko R, Bouslany G, Huang PL, Kantarei A, Van Dyke TE, Genco CA, et ai (2003). Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun 71:4917-4924.
12. Gyurko R, Shoji H, Battaglino RA, Boustany G, Gibson FC 3rd, Genco CA, et al. (2005). Inducible nitric oxide synthase mediates bone development and P. gingivalis-induced alveolar bone loss. Bone 36:472-479.
13. Hama S, Takeichi O, Saito I, Ito K (2007). Involvement of inducible nitric oxide synthase and receptor for advanced glycation end products in periapical granulomas. J Endod 33:137-141.
14. Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM (2001). Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 40:623-630.
15. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, et al. (1997). Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEBJ 11:955-964.
16. Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL (2006). Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res 21:67-77.
17. Kawashima N, Niederman R, Hynes RO, Ullmann-Cullere M, Stashenko P (1999). Infection-stimulated infraosseus [sic] inflammation and bone destruction is [sic] increased in P-/E-selectin knockout mice. Immunology 97:117-123.
18. Kawashima N, Nakano-Kawanishi H, Suzuki N, Takagi M, Suda H (2005). Effect of NOS inhibitor on cytokine and COX2 expression in rat pulpitis. J Dent Res 84:762-767.
19. Lappin DF, Kjeldsen M, Sander L, Klnane DF (2000). Inducible nitric oxide synthase expression in periodontitis. J Periodontal Res 35:369-373.
20. Laubach VE, Shesely EG, Smithies O, Sherman PA (1995). Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaceharide-induced death. Proc Natl Acad Sci USA 92:10688-10692.
21. Lin SK, Kok SH, Lin LD, Wang CC, Kuo MY, Lin CT, et al. (2007). Nitric oxide promotes the progression of periapical lesion via inducing macrophage and osteoblast apoptosis. Oral Microbiol Immunol 22:24-29.
22. MacIntyre I, Zaidi M, Alam AS, Datta HK, Moonga BS, Lidbury PS, et al. (1991). Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Nail Acad Sci USA 88:2936-2940.
23. McCartney-Francis NL, Song X, Mizel DE, Wahl SM (2001). Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol 166:2734-2740.
24. Nair PN (1997). Apical periodontitis: a dynamic encounter between root canal infection and host response. Periodontal 2000 13:121-148.
25. Ralston SH, Ho LP, Helfrieh MH, Grabowski PS, Johnston PW, Benjamin N (1995). Nitric oxide: a cytokine-induecd regulator of bone resorption. J Bone Miner Res 10:1040-1049.
26. Roux S, Orcel P (2000). Bone loss. Factors that regulate osteoclast differentiation: an update. Arthritis Res 2:451-456.
27. Suzuki N, Okiji T, Suda H (1999). Enhanced expression of activation-associated molecules on macrophages of heterogeneous populations in expanding periapical lesions in rat molars. Arch Oral Biol 44:67-79.
28. Takeichi O, Saito I, Hayashi M, Tsurumachi T, Saito T (1998). Production of human-inducible nitric oxide synthase in radicular cysts. J Endod 24:157-160.
29. van't Hof RJ, Ralston SH (1997). Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res 12:1797-1804.
30. van't Hof RJ, Ralston SH (2001). Nitric oxide and bone. Immunology 103:255-261.
31. Veihelmann A, Landes J, Hofbauer A, Dorger M, Refior HJ, Messmer K, et al. (2001). Exacerbation of antigen-induced arthritis in inducible nitric oxide synthase-deficient mice. Arthritis Rheum 44:1420-1427.
32. Vernal R, Dezerega A, Dutzan N, Chaparro A, Leon R, Chandia S, et al. (2006). RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis 12:283-289.
33. Wada T, Nakashima T, Hiroshi N, Penninger JM (2006). RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17-25.
34. Wang FS, Wang CJ, Chen YJ, Huang YT, Huang HC, Chang PR, et al. (2004). Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats. Endocrinology 145:2148-2156.
35. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, et al. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
36. Wright LM, Maloney W, Yu X, Kindle L, Collin-Osdoby P, Osdoby P (2005). Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactie recruitment, development and survival of human osteoclasts. Bone 36:840-853.